Haemonetics (HAE) Retained Earnings (2010 - 2026)

Haemonetics has reported Retained Earnings for 17 years, with the latest figure at -$37.6 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings rose 31.72% year-over-year to -$37.6 million; the trailing twelve-month figure through Mar 2026 stood at -$37.6 million (up 31.72% YoY), and the FY2026 full-year result was -$37.6 million, up 31.72% from the prior year.
• Retained Earnings for Q1 2026 stood at -$37.6 million, down from $381.1 million in the prior quarter.
• The five-year high for Retained Earnings was $386.6 million in Q2 2024, with the low at -$55.5 million in Q4 2024.
• Average Retained Earnings over 5 years is $135.9 million, with a median of $84.1 million recorded in 2022.
• Peak annual rise in Retained Earnings reached 1226.85% in 2024, while the deepest fall reached 127.63% in 2024.
• Tracing HAE's Retained Earnings over 5 years: stood at $223.8 million in 2022, then sank by 110.9% to -$24.4 million in 2023, then tumbled by 127.63% to -$55.5 million in 2024, then jumped by 786.64% to $381.1 million in 2025, then plunged by 109.87% to -$37.6 million in 2026.
• The last three Retained Earnings figures came in at -$37.6 million (Q1 2026), $381.1 million (Q4 2025), and $336.3 million (Q3 2025), per Business Quant data.

Peer Comparison